Meritage Homes Corporation (MTH) Stock Analysis

Company Overview

Meritage Homes Corporation is a leading developer that designs and builds single-family attached and detached residences throughout the United States, operating primarily through its Homebuilding and Financial Services segments. The enterprise functions within the Consumer Cyclical sector, specifically the Residential Construction industry, where its performance is intrinsically linked to housing demand and macroeconomic conditions. This entity manages a substantial workforce of 1,860 employees while maintaining a total market capitalization of $4.22 billion and generating annual revenue of $5.86 billion. These valuation and revenue figures indicate a significant market presence, positioning the company as a major player capable of leveraging economies of scale in a highly competitive landscape.

Financial Health

The company reported a trailing twelve-month revenue of $5.86 billion, with a corresponding net income of $453.01 million and EBITDA of $586.57 million. The substantial gap between the $5.86 billion revenue and the $453.01 million net income reveals a cost structure where operating expenses, including cost of goods sold and administrative costs, consume approximately 92.3% of total revenue before reaching the bottom line. Free cash flow stands at -$16.33 million, indicating a current period of capital outflow that suggests the company is prioritizing capital expenditures or debt management over immediate cash generation. Gross margin is recorded at 20.1%, while the operating margin is 7.5% and the profit margin is 7.7%, reflecting the thin spreads typical of the homebuilding industry where material costs heavily impact profitability. The balance sheet holds $775.16 million in cash against $1.89 billion in total debt, resulting in a debt-to-equity ratio of 36.37, which characterizes the firm as moderately leveraged rather than conservatively funded. A current ratio of 13.69 demonstrates exceptional short-term liquidity, providing a robust buffer to meet immediate obligations without reliance on external financing. Return on equity is 8.8% and return on assets is 4.7%, metrics that reveal management's effectiveness in generating returns relative to the capital invested by shareholders and the total asset base utilized.

Valuation Assessment

The stock trades with a trailing P/E ratio of 9.45 and a forward P/E of 7.97, a divergence that implies the market expects earnings to decline further before stabilizing or growing in the coming years. The price-to-book ratio is 0.79, indicating that the market values the company at a discount to its book value, which often reflects concerns regarding asset quality or future earnings power in a cyclical sector. Alternative valuation metrics such as a price-to-sales ratio of 0.72 and an EV/EBITDA of 8.73 suggest the market is pricing the company conservatively relative to its sales volume and earnings before interest, taxes, depreciation, and amortization. Over the past year, the stock has fluctuated between a 52-week high of $84.74 and a 52-week low of $58.03, trading at a level that reflects a significant distance below the recent peak. With a beta of 1.45, the stock exhibits higher volatility than the broader market, meaning its price movements are amplified by general market fluctuations more than the average stock.

Growth & Income

Year-over-year revenue growth stands at -11.5%, while earnings growth has contracted even more sharply at -48.8%, indicating that earnings are declining at a much faster rate than revenue due to margin compression or cost inflation. The company maintains a dividend yield of 3.2% with a payout ratio of 27.1%, suggesting that the dividend payment is covered by a small fraction of earnings, which theoretically offers a cushion but must be scrutinized given the recent negative earnings growth trajectory. The negative growth rates across both revenue and earnings highlight a challenging operational environment where the company is currently shrinking its top line and bottom line simultaneously.